No ano passado, Clearpoint Neuro Inc gerou US$ 14.83M em seu segmento de melhor desempenho, Products: Functional neurosurgery. A região United States teve a maior contribuição, com US$ 36.97M no período. No último trimestre, Clearpoint Neuro Inc registrou receita de US$ 5.55M no período encerrado em 2026-06-30, proveniente principalmente do segmento Products: Functional neurosurgery. A região United States teve a maior contribuição, com receita de US$ 10.88M.

Por Empresa

Receita

Proporção

Anual

Anual

Trimestral

Products: Functional neurosurgery

Services: Biologics and drug delivery

Products: Biologics and drug delivery

Product Systems and software products

Services: Capital equipment and other

Services -Functional neurosurgery navigation and therapy

Products: Capital equipment

Services Therapy

Products:Therapy

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Products: Functional neurosurgery

14.83M(40.12%)

10.29M(32.77%)

7.59M(31.68%)

7.59M(36.92%)

7.70M(47.22%)

6.27M(48.88%)

6.88M(61.37%)

Services: Biologics and drug delivery

11.70M(31.65%)

11.70M(37.29%)

11.45M(47.79%)

5.43M(26.42%)

3.44M(21.12%)

3.58M(27.87%)

889.70K(7.93%)

Products: Biologics and drug delivery

7.34M(19.85%)

5.61M(17.86%)

2.15M(8.99%)

3.69M(17.96%)

3.35M(20.57%)

1.47M(11.44%)

1.46M(13.01%)

Product Systems and software products

1.69M(4.57%)

2.73M(8.71%)

860.00K(3.59%)

1.51M(7.36%)

864.00K(5.30%)

440.00K(3.43%)

--(--)

Services: Capital equipment and other

1.41M(3.81%)

1.06M(3.38%)

973.00K(4.06%)

795.00K(3.87%)

569.00K(3.49%)

1.05M(8.18%)

625.87K(5.58%)

Services -Functional neurosurgery navigation and therapy

--(--)

931.00K(3.89%)

1.54M(7.48%)

375.00K(2.30%)

25.00K(0.19%)

--(--)

Products: Capital equipment

--(--)

1.04M(9.24%)

Services Therapy

--(--)

225.00K(2.01%)

Products:Therapy

--(--)

96.92K(0.86%)

Por Região

Receita

Proporção

Anual

Anual

Trimestral

United States

FY2025

FY2024

FY2023

United States

36.97M(100.00%)

31.39M(100.00%)

23.95M(100.00%)